S-CEI of Nexium in Paediatric Patients

CompletedOBSERVATIONAL
Enrollment

240

Participants

Timeline

Start Date

June 28, 2018

Primary Completion Date

November 5, 2020

Study Completion Date

November 5, 2020

Conditions
Peptic Ulcer, Gastroesophageal Reflux
Trial Locations (31)

Unknown

Research Site, Aichi

Research Site, Akita

Research Site, Chiba

Research Site, Ehime

Research Site, Fukui

Research Site, Fukuoka

Research Site, Fukushima

Research Site, Gifu

Research Site, Gunma

Research Site, Hiroshima

Research Site, Hokkaido

Research Site, Hyōgo

Research Site, Ibaraki

Research Site, Kagawa

Research Site, Kanagawa

Research Site, Kochi

Research Site, Kumamoto

Research Site, Mie

Research Site, Miyagi

Research Site, Nagano

Research Site, Nagasaki

Research Site, Numakunai

Research Site, Osaka

Research Site, Saga

Research Site, Saitama

Research Site, Shizuoka

Research Site, Tochigi

Research Site, Tokushima

Research Site, Tokyo

Research Site, Toyama

Research Site, Yamagata

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT03562026 - S-CEI of Nexium in Paediatric Patients | Biotech Hunter | Biotech Hunter